WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion.
II: Side effects and women's perceptions
Article first published online: 27 APR 2004
BJOG: An International Journal of Obstetrics & Gynaecology
Volume 111, Issue 7, pages 715–725, July 2004
How to Cite
Honkanen, H., Piaggio, G., von Hertzen, H., Bártfai, G., Erdenetungalag, R., Gemzell-Danielsson, K., Gopalan, S., Horga, M., Jerve, F., Mittal, S., Thi Nhu Ngoc, N., Peregoudov, A., Prasad, R.N.V., Pretnar-Darovec, A., Shah, R. S., Song, S., Tang, O. S., Wu, S. C. and For the WHO Research Group on Post-Ovulatory Methods for Fertility Regulation (2004), WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. BJOG: An International Journal of Obstetrics & Gynaecology, 111: 715–725. doi: 10.1111/j.1471-0528.2004.00153.x
- Issue published online: 27 APR 2004
- Article first published online: 27 APR 2004
- 3World Health Organization. Task Force on Post-Ovulatory Methods of Fertility Regulation. Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: a randomised trial. Br J Obstet Gynaecol 2000;107: 524–530.
- 8The use of low dose mifepristone and vaginal misoprostol for first trimester termination of pregnancy. Br J Fam Plan 1995;106: 85–86., .
- 11AHFS. AHFS Drug Information. Bethesda: American Society of Health-System Pharmacists, 2002: 2849–2855.
- 14WHO-UMC (WHO Collaborating Centre for International Drug Monitoring). Available: http://www.who-umc.org. Search on adverse reactions to misoprostol, performed in May 2002.